Omega-3 Index: The Heart Health Blood Test Most People Skip

What the Omega-3 Index Measures

The omega-3 index (O3I) is expressed as the sum of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) as a percentage of total fatty acids in red blood cell membranes. Red blood cells have a lifespan of about 120 days, so the omega-3 index is a stable, 3–4 month average measure of omega-3 status — unaffected by what you ate yesterday or last week.

This makes it more reliable than simply measuring omega-3 levels in plasma (which reflect recent intake) or relying on dietary recall. The omega-3 index was developed by researchers William Harris and Clemens von Schacky in 2004 and has since been validated in dozens of prospective studies as a cardiovascular risk marker.

Omega-3 Index Target Ranges

Omega-3 Index	Risk Category	Population Prevalence
Below 4%	High cardiovascular risk zone	Common in US, Canada, UK
4–8%	Intermediate risk zone	Most Westerners
8–12%	Optimal (target) zone	Japan, some Scandinavian countries
Above 12%	Exceeds typical supplementation targets	Very high fish consumers

The average omega-3 index in the United States is estimated at 5–6%. In Japan — where fish consumption is high and cardiovascular disease rates are low — the average is closer to 9–10%. This geographic distribution aligns with the cardiovascular risk data: populations with higher omega-3 indices consistently have lower rates of cardiac death.

Cardiovascular Risk and the Omega-3 Index

The landmark finding from the Harris and von Schacky paper was that people with an omega-3 index below 4% had approximately 10 times the risk of sudden cardiac death compared to those with an index above 8%. Subsequent analyses from prospective cohorts including the Framingham Heart Study have confirmed that a low omega-3 index independently predicts cardiovascular events, independent of LDL cholesterol, blood pressure, and other traditional risk factors.

The mechanism involves several pathways: EPA and DHA are incorporated into cell membranes throughout the cardiovascular system, where they reduce platelet aggregation, lower triglycerides (high EPA/DHA intake reduces triglycerides by 20–30%), reduce inflammation, stabilise cardiac electrical activity (reducing arrhythmia risk), and improve endothelial function.

Omega-3, Brain Health, and Cognitive Function

DHA is the dominant fatty acid in the brain — it makes up approximately 40% of the polyunsaturated fatty acids in brain grey matter. Low DHA status is associated with smaller brain volume, accelerated cognitive decline, and increased risk of Alzheimer's disease in observational studies. Prospective studies show that higher omega-3 index is associated with better executive function, verbal memory, and processing speed in older adults.

The omega-3 index has been proposed as a modifiable biomarker for brain ageing alongside cardiovascular ageing. For both outcomes, the optimal target appears to be 8–12%.

How to Improve Your Omega-3 Index

The omega-3 index rises when EPA and DHA intake increases. The most effective dietary source is fatty fish: salmon, mackerel, sardines, herring, and anchovies contain 1–3 grams of EPA+DHA per serving. Eating 2–3 portions of fatty fish per week can raise the omega-3 index by 1–3 percentage points over 3–4 months.

For those who do not eat fish regularly, high-quality fish oil or algae-based omega-3 supplements are effective. The dose required to reach the 8% target varies by individual baseline — typical doses of 1–2 g EPA+DHA daily are needed for most people starting below 5%. Note: high-dose omega-3 supplements can increase bleeding risk and may interact with anticoagulants (warfarin, heparin) and antiplatelet drugs (aspirin, clopidogrel). Discuss with your doctor before supplementing if you take any of these. Triglyceride-form fish oil (found in most liquid fish oils and some capsules) is absorbed better than ethyl-ester form (found in most standard capsules) when taken with food.

Plant-based sources of omega-3 (ALA from flaxseeds, chia, walnuts) are poorly converted to EPA and DHA in humans — the conversion rate is typically under 5–10%. ALA intake does not meaningfully raise the omega-3 index. Only preformed EPA and DHA — from fish, fish oil, or algae oil — will move the needle.

EPA vs DHA: Do Both Count?

Both EPA and DHA contribute to the omega-3 index, but they have different primary effects. EPA has the stronger anti-inflammatory and anti-platelet role, and recent trial data (REDUCE-IT) showed high-dose EPA alone (as icosapentaenoic acid / Vascepa, a prescription-only medication) significantly reduced cardiovascular events in high-risk patients. DHA is the dominant brain fatty acid and has stronger effects on triglyceride reduction and visual function.

For general cardiovascular and brain health, a combination product containing both EPA and DHA is recommended. The omega-3 index counts the sum of both, and most research on the index uses the combined measure. Achieving 8% typically requires sustained supplementation plus dietary intake for several months.